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Background. Urinary tract infection is the most frequent health care–associated complication. We hypothesized
that the implementation of a multifaceted prevention strategy could decrease its incidence after surgery.
Methods. In a controlled, prospective, before-after intervention trial with 1328 adult patients scheduled for
orthopedic or abdominal surgery, nosocomial infection surveillance was conducted until hospital discharge. A
multifaceted intervention including specifically tailored, locally developed guidelines for the prevention of urinary
tract infection was implemented for orthopedic surgery patients, and abdominal surgery patients served as control
subjects. Infectious and noninfectious complications, adherence to guidelines, and antibiotic use were monitored
before and after the intervention and again 2 years later.
Results. The incidence of urinary tract infection decreased from 10.4 to 3.9 episodes per 100 patients in the
intervention group (incidence-density ratio, 0.41; 95% CI, 0.20–0.79; ). Adherence to guidelines wasPp .004
82.2%. Both the frequency and the duration of urinary catheterization decreased following the intervention.
Recourse to antibiotic therapy after surgery dropped in the intervention group from 17.9 to 15.6 defined daily
doses per 100 patient-days ( ) because of a reduced need for the treatment of urinary tract infectionP ! .005
( ). Follow-up after 2 years revealed a sustained impact of the strategy and a subsequent low use of antibiotics,P ! .001
consistent with stable adherence to guidelines (80.8%).
Conclusions. A multifaceted prevention strategy can dramatically decrease postoperative urinary tract infection
and contribute to the reduction of the overall use of antibiotics after surgery.
Urinary tract infection (UTI) is the most common health
care–associated adverse event and the leading nosocomial
complication following joint prosthesis surgery [1, 2].
Presence of an indwelling urinary catheter is the main
risk factor for infection [1, 3, 4]. In addition to the
associated economic burden and patient morbidity [1,
2, 5, 6], UTIs contribute to the inappropriate and ex-
cessive use of antimicrobial agents and lead to the se-
lection of antibiotic-resistant organisms, thereby creating
a potential reservoir of resistant pathogens [1, 3, 7].
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In most hospitals, urinary catheters are placed by
anesthesiologists in the operating room and the pos-
tanesthesia care unit, and surgeons and nurses handle
the placement of indwelling devices for patients in the
surgical ward. Management of urinary problems relies
more on the physician’s experience and the surgery
department’s practice patterns than on evidence-based
data. Specific recommendations related to urinary cath-
eter placement during surgical procedures are lacking
not only in anesthesiology and surgery textbooks, but
also in published guidelines issued by local and national
authorities [8–10]. We performed a multifaceted, mul-
tidisciplinary intervention study to decrease the inci-
dence of nosocomial UTI in surgical patients and
thereby improve quality of care and patient safety.
METHODS
Study design. We conducted a 3-phase, controlled,
prospective, before-after intervention trial (quasi-ex-
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Figure 1. Study design and patient flow diagram. During phase I, 5 abdominal surgery patients and 58 orthopedic surgery patients were transferred
directly from the operating room to the surgical wards. During phase II, 2 abdominal surgery patients and 54 orthopedic surgery patients were
transferred directly from the operating room to the surgical wards. During phase III, 56 orthopedic surgery patients were transferred directly from the
operating room to the surgical ward. Grey shading indicates the locations where the intervention was conducted. ICU, intensive care unit; PACU,
postanesthesia care unit.
perimental study) with patients scheduled to undergo surgery
in the orthopedic and abdominal surgery departments who
were, therefore, likely to be exposed to urinary catheterization.
The study was classified as B1 in the hierarchy of quasi-ex-
perimental study designs proposed by Harris and colleagues
[11]. The study was approved by the institutional review board
of the University of Geneva Hospitals, Geneva, Switzerland; no
informed consent was requested.
Orthopedic surgery patients were assigned to the interven-
tion group; abdominal surgery patients served as control sub-
jects (figure 1). Baseline surveillance was conducted from No-
vember 2001 to January 2002 in both groups (phase I).
Guidelines for perioperative urinary catheter insertion and
management in orthopedic surgery patients were implemented
in February 2002. Surveillance after the intervention continued
in both groups from March to June 2002 (phase II). Follow-
up surveillance (phase III) was conducted 2 years later, from
April to June 2004, and included only orthopedic surgery
patients.
Data collection. Variables included age, weight, height,
body mass index, sex, comorbidities, immunosuppressive ther-
apy, dates of admission and discharge from the hospital, date
and type of surgery, American Society of Anesthesiologists
(ASA) class [12], anesthetic technique, duration of anesthesia
and surgical procedure, the need for transfusion of blood prod-
ucts, and total volume of intravascular infusion. In the pos-
tanesthesia care unit, the total dose of morphine, frequency of
bladder volume determination, and the need for urinary cath-
eterization were also recorded.
Surveillance. Surveillance of nosocomial infections was
performed by a single infection-control physician who visited
the postanesthesia and surgical wards daily (6 days per week)
and completed a dedicated surveillance chart for each patient
until hospital discharge. Infections were prospectively identified
according to standard definitions [13,14]. In the surgical ward,
the need for urinary catheterization and the duration of cath-
eterization were noted. All surveillance records were reviewed
and validated by a senior hospital epidemiologist.
Patients were questioned daily by the infection control phy-
sician regarding any discomfort or other symptoms potentially
associated with the catheter, such as urethral or pelvic pain and
a sense of urgency or dysuria, and records were reviewed for
fever, antibiotic use, and clinical and laboratory data suggesting
infection. Urine analysis was performed systematically after
catheter removal or at the attending physician’s discretion. A
quantitative urine culture was performed if laboratory analysis
suggested infection (e.g., suggested the presence of bacteriuria,
pyuria, leukocyturia, or significant hematuria or positive test
results for nitrite), or if the patient had symptoms of UTI or
a fever of unknown origin.
Noninfectious complications were prospectively recorded us-
ing a complete patient chart review and an interview with the
attending physician or nurse. These complications included
cardiovascular events, such as pulmonary embolism, stroke,
acute pulmonary edema, and myocardial infarction; need for
reoperation; need for transfusion of RBCs; and occurrence of
bed sores.
Surveillance protocols were unchanged during the 3 phases.
Patient care protocols and intervention. Indwelling uri-
nary tract catheters (Silkotalex Rusch Gold; Ru¨sch GmbH) were
inserted using the aseptic technique and sterile equipment [10]
and were connected to a closed drainage system [15]. The
intervention focused on perioperative urinary catheter man-
agement for orthopedic surgery patients. We designed a mul-
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Table 1. Characteristics of orthopedic surgery patients during each study phase.
Variable
Preintervention
(n p 280)
Postintervention
(n p 259)
2-year follow-up
(n p 300) P
Age in years (range) 60.2 (16–97) 59.8 (17–93) 58.7 (16–98) .62
Sex .36
Male 132 (47) 113 (44) 149 (50)
Female 148 (53) 146 (56) 151 (50)
Body mass index (range) 25.7 (13.1–50.7) 25.8 (11.4–41.4) 26.3 (12.7–57.2) .38
ASA class 12 76 (27.0) 56 (22.0) 61 (20.3) .12
Diabetes mellitus 29 (10.3) 26 (10.0) 32 (10.7) .97
Immunodepression 7 (2.5) 5 (2.0) 12 (4.0) .31
Malnutrition 2 (0.7) 5 (1.9) 8 (2.7) .20
Obesity 64 (22.8) 53 (20.5) 69 (23) .72
Procedures .24
Total hip replacement 72 (26.0) 68 (26.2) 80 (26.7)
Total knee replacement 42 (15.0) 29 (11.2) 46 (15.3)
Lower limb surgery 42 (15.0) 32 (12.4) 46 (15.3)
Foot surgery 45 (16.0) 52 (20.0) 37 (12.3)
Upper limb surgery 33 (11.8) 37 (14.3) 39 (13.0)
Removal of orthopedic material 23 (8.2) 29 (11.2) 37 (12.3)
Miscellaneous 23 (8.2) 12 (4.6) 15 (5.0)
Anesthetic techniques .52
General anesthesia with and without peripheral
nerve blocks 163 (58.2) 157 (60.6) 188 (62.7)
Spinal or epidural anesthesia with and without
peripheral nerve blocks 57 (20.3) 38 (14.7) 44 (14.7)
General plus spinal or epidural anesthesia 4 (1.4) 4 (1.5) 6 (2.0)
Peripheral nerve blocks 56 (20.0) 60 (23.2) 62 (20.7)
Volume infusion during procedure, mL (range) 1406 (100–5250) 1543 (220–8500) 1404 (100–8000) .12
Dose of morphine administered in PACU, mg (range) 11.5 (1–60) 10.5 (1–60) 12.0 (2–189) .70
Duration of hospitalization, mean days (range) 15.9 (1–167) 14.1 (1–107) 14.2 (1–161) .27
Patient-days of follow-up 4462 3648 4261
NOTE. Data are no. (%) of patients, unless otherwise indicated. ASA, American Society of Anesthesiologists; PACU, postanesthesia care unit.
tifaceted intervention that combined specifically tailored, locally
developed guidelines, educational sessions, and posters with a
visual display of the guidelines. Guidelines were applied in the
operating room, postanesthesia care unit, and surgical ward
(figure 1). Criteria for the placement and management of uri-
nary catheters in the operating room, postanesthesia care unit,
and surgical ward follow.
In the operating room, urinary catheterization was restricted
to patients with (1) interventions with a foreseen duration of
surgery 15 hours; (2) total hip replacement or related surgery,
if the patient met 1 of the following conditions: age 175 years,
an ASA class3, obesity, or urinary incontinence; and (3) total
knee replacement, if the patient met 1 of the following con-
ditions: age 180 years, obesity, or urinary incontinence.
In the postanesthesia care unit, the decision to insert a uri-
nary catheter followed these criteria: (1) the decision required
the clinical judgment of a physician; (2) there was no routine
requirement for urination before discharge [16]; (3) there was
no routine determination of bladder volume by ultrasound and
no decision for catheterization based on bladder volume mea-
surement; and (4) a urinary catheter inserted because of long-
duration surgery must be removed before discharge from the
unit.
In the surgical wards, the urinary catheter was removed (1)
on postoperative day 2 (i.e., the third day of catheterization)
after total hip replacement or related surgery or (2) on post-
operative day 1 after total knee replacement.
These guidelines were approved by the orthopedic depart-
ment chair, senior nurses, and senior anesthetists of our insti-
tution. Rotating resident anesthetists were individually in-
structed. After an educational presentation on the epidemiology
and prevention of UTI, guidelines were endorsed by nursing
staff. Additional information was also given individually to
nurses and physicians upon request. A4-format posters illus-
trating the guidelines and endorsed by the orthopedic depart-
ment senior staff (department chair, senior nurse, and chief
anesthetist) and the hospital infection control program director
were displayed in all operating rooms dedicated to orthopedic
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Table 2. Urinary tract infection during preintervention and postintervention phases.
Patients with urinary
tract infection
Preintervention phase
(n p 529)
Postintervention phase
(n p 499)
Incidence density
ratio (95% CI)
No. of episodes
(per 100 patients)
Incidence
densitya
No. of episodes
(per 100 patients)
Incidence
densitya
Overall 35 (6.6) 27.0 13 (2.6) 12.0 0.44 (0.24–0.81)
Orthopedic surgery 29 (10.4) 45.8 10 (3.9) 18.6 0.41 (0.20–0.79)
Abdominal surgery 6 (2.4) 9.0 3 (1.25) 5.6 0.62 (0.14–2.50)
a Defined as the no. of episodes per 1000 catheter-days.
procedures, the postanesthesia care unit, and orthopedic nurs-
ing staff offices. Feedback on practice and results was provided
6 months after the completion of phase II.
Outcome measures. UTI was the primary outcome mea-
sure. The incidence rate refers to the number of new cases of
infection per 100 patients. The device-associated incidence den-
sity refers to the number of new episodes of infection per 1000
urinary catheter–days. Antimicrobial use during the postop-
erative period was the secondary outcome measure, summa-
rized by defined daily dose per 100 patient-days [17].
Statistical analysis. The reported incidence of UTI among
orthopedic surgery patients is around 10% [18–20]; a target
sample size of 310 patients (155 patients each for phases I and
II) would be an accurate estimate to ensure with 90% proba-
bility the detection of a 30% reduction in the incidence of UTI
between phase I and phase II among the intervention group.
Continuous variables were expressed as the mean or median
when appropriate. x2 Tests or Fisher’s exact test were used to
compare proportions and rates, and continuous variables were
compared using Student’s t test or the Mann-Whitney U test
when appropriate. Analysis of variance was used to compare
demographic data among the 3 phases for orthopedic surgery
patients. Data were analyzed using Statview software, version
5.0 (SAS Institute). A P value !.05 was considered to be sta-
tistically significant.
RESULTS
Patient Population and Overall Incidence of UTI
A total of 1328 patients were prospectively surveyed: 529 pa-
tients before intervention (phase I), 499 patients immediately
after intervention (phase II), and 300 patients during the 2-
year follow-up (phase III) (figure 1). Patient characteristics at
baseline, surgical procedures, anesthetic techniques, and me-
dian dose of morphine administered in the postanesthesia care
unit were similar during the 3 phases for orthopedic surgery
patients (table 1) and during the first 2 phases for abdominal
surgery patients (data not shown). After surgery, 1107 (83%)
of 1328 patients were transferred to the postanesthesia care
unit, 175 (13%) of 1328 returned directly to the surgical ward,
and 46 (4%) were admitted to the surgical intensive care unit.
The overall incidence of UTI in the study population was
6.6 episodes per 100 patients in phase I versus 2.6 episodes per
100 patients in phase II (table 2) (relative risk, 0.39; 95% CI,
0.21–0.71). The frequency of UTI increased with the severity
of underlying illness (among ASA class 1 patients, 1.4%; among
ASA class 2 patients, 3.3%; among ASA class 3 patients, 9.7%;
among ASA class 4 patients, 17.4%; ). Infection de-P ! .0001
veloped after a median of 6.5 days (range, 2–44 days) of cath-
eterization. Most infections (80.5%) were monomicrobial, with
enterobacteriaceae as the predominant pathogens (72% of
monomicrobial infections). Pathogen distribution was similar
in the 3 study phases; the most common isolates were Esche-
richia coli (52%), other enterobacteriaceae (20%), enterococci
(11%), Pseudomonas aeruginosa (7%), and Candida species
(9%).
Intervention Group: Orthopedic Surgery Patients
Impact of intervention. Twenty-nine hospital-acquired UTIs
were observed during phase I versus 10 UTIs during phase II
( ), which represents a 59% decrease in the incidencePp .004
density of UTI (table 2). The frequency of performance of urine
analysis following urinary catheter removal was similar in
phases I and II (93 [91%] of 102 patients and 76 [90%] of 84
patients, respectively; ).Pp .87
Adherence with guidelines was 82.2%. Bladder catheteriza-
tion in the postanesthesia care unit or surgical ward was per-
formed in 11 patients (3.9%) during phase I and in 17 patients
(6.6%) during phase II ( ). A significantly higher pro-Pp .17
portion of patients had a urinary catheter for 3 days after
intervention, and a shorter mean duration of catheterization
was also observed (table 3).
The occurrence of infectious complications other than UTI,
as well as noninfectious complications, was similar during
phases I and II (table 4). Overall recourse to antibiotic therapy
after surgery decreased from 17.6 defined daily doses in phase
I to 15.6 defined daily doses in phase II ( ) because ofP ! .005
the reduced need for the treatment of UTI (table 4). Three
patients died during phase I, and 2 died during phase II
( ); deaths were unrelated to UTI.Pp .71
Follow-up at 2 years. Eleven hospital-acquired UTIs were
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Table 3. Urinary bladder management in orthopedic surgery patients during the study phases.
Variable
Preintervention
(n p 280)
Postintervention
(n p 259) Pa
2-year follow-up
(n p 300) Pb
Urinary-bladder management in operating room
Initial urinary catheterization 88 (31.5) 62 (24.0) .052 47 (15.7) .01
Intermittent catheterization 1 (0.4) 1 (0.4) 1.99 0 .46
Previous long-term urinary catheterization 15 (5.4) 17 (6.5) .55 15 (5.0) .43
Bladder ultrasound examination in PACU 28 (12.8) 21 (10.4) .46 4 (1.7) !.001
Urinary catheterization in PACUc 4 (1.4) 8 (3.0) .19 3 (1.0) .08
Urinary catheterization in surgical wardc 7 (2.5) 9 (3.5) .5 11 (3.7) .90
No. of days of urinary catheterizationd (range) 5.0 (1–29) 3.9 (1–31) .02 6.4 (1–56) .05
Duration of urinary catheterization 3 daysd 50 (51.5) 49 (67.0) .04 24 (43.0) .006
NOTE. Data are no. (%) of patients, unless otherwise indicated. PACU, postanesthesia care unit.
a Phase I versus phase II.
b Phase II versus phase III.
c Includes indwelling urinary catheter and intermittent catheterization.
d Patients with long-term urinary catheterization were excluded.
observed during phase III, with an incidence of 3.7 episodes
per 100 patients; the incidence density of infection remained
low: 21.2 episodes per 1000 catheter-days. Urine analysis was
performed 53 times following urinary catheter removal (82%,
, compared with phase II). Adherence with guidelinesPp .11
was 80.8%. Only 47 of 300 orthopedic procedures (15.7%) were
performed after urinary catheter placement in the operating
room (table 3). Bladder catheterization in the postanesthesia
care unit or surgical ward was performed in 14 patients (4.7%;
not significant, compared with phase II).
The occurrence of noninfectious and infectious complica-
tions other than UTI is shown in table 4. Despite a higher
incidence density of pneumonia, recourse to antibiotic therapy
following surgery remained stable, compared with phase II,
which is consistent with a reduced need for the treatment of
UTI ( ) (table 4). Two patients died; deaths were un-Pp .002
related to UTI.
Control Group: Abdominal Surgery Patients
The incidence of UTI was stable during the 2 phases of ob-
servation (table 2). The frequency of the performance of urine
analysis following urinary catheter removal was similar in
phases I and II (101 [89%] of 114 patients vs. 76 [86%] of 88
patients; ). In the postanesthesia care unit, bladder ul-Pp .63
trasound examination was performed 42 times during phase I
and 20 times during phase II ( ). Bladder ultrasoundPp .005
examination tended to be less frequent in phase II with 3 pa-
tients, compared with 10 patients in phase I ( ). ThePp .06
incidence of urinary catheterization in the surgical ward re-
mained unchanged at 2%. Nine episodes of bloodstream in-
fection were recorded in phase I, and none were recorded in
phase II ( ); 2 episodes were secondary to UTI. ThePp .008
occurrence of other infectious complications was similar during
both phases. The overall use of antibiotics was higher in phase
I (16.6 defined daily doses vs. 11.9 defined daily doses in phase
II; ) because of increased recourse for the treatment ofP ! .001
bloodstream infection. Three patients died; deaths were un-
related to UTI.
DISCUSSION
The incidence of UTI following orthopedic surgery decreased
by two-thirds following the intervention, and its benefit per-
sisted after 2 years. The impact of such a prevention strategy
could be very substantial both for patient safety and con-
sumption of health care resources. The 2002 National Hospital
Discharge Survey reported estimates of 574,000 total joint ar-
throplasties performed in nonfederal hospitals each year [21].
Considering a basic incidence of ∼10%, 123,000 UTIs could
be avoided each year in the United States, which would result
in considerable economic cost savings and reduction in anti-
biotic use.
We focused our intervention on orthopedic surgery patients.
Of note, the 10.4% incidence rate observed during the pre-
intervention phase among these patients is within the expected
ranges of published prospective studies which report rates of
6%–24% with a mean average of 12% [5, 18, 20]. Besides
generating extra hospital costs, these infections are a source of
gram-negative secondary bacteremia in 0.5–7.7 of 100 patients
[2, 7], with potential harmful damage and additional hospital
expenditure [1, 16, 22, 23] and may constitute an important
reservoir for the selection and spread of multidrug-resistant
organisms [3]. Studies have also suggested severe morbidities
associated with UTI [5, 6, 24, 25], in particular, distant joint
infections after hip or knee arthroplasty [24, 25].
Exposure to a urinary catheter is the major risk factor for
infection [1, 3, 4, 7]. Intraluminal colonization by reflux of
organisms from a contaminated drainage bag or by a break in
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Table 4. Nosocomial infections other than urinary tract infection, antibiotic consumption, noninfectious com-
plications, and RBC transfusion over the study phases in orthopedic surgery patients.
Variable
Preintervention
(n p 280)
Postintervention
(n p 259) Pa
2-year follow-up
(n p 300) Pb
Incidence density of nosocomial infections
other than urinary tract infectionc
Pneumonia 0.44 0.0 .15 1.40 .02
Surgical site infection 1.30 0.27 .17 1.17 .14
Bloodstream infection 0.22 0 .70 0
Miscellaneous 0.67 1.09 .50 2.11 .25
Antibiotic therapy following surgery, DDD
per 100 patient-days
Antibiotics for urinary tract infection 3.9 2.0 !.001 1.15 .002
Antibiotics for other reasons 14.0 13.6 .52 15.6 .01
No. of patients with noninfectious
complications 18 13 .46 24 .14
Reoperation 9 5 6
Cardiovascular events 1 3 8
Bed sores 4 3 2
Miscellaneous 4 2 8
No. (%) of patients with RBC transfusion 92 (33) 75 (29) .33 86 (29) .93
NOTE. DDD, defined daily dose.
a Phase I versus phase II.
b Phase II versus phase III.
c Defined as the no. of episodes per 1000 patient-days.
the closed drainage system is now a rather infrequent event [3,
7, 14, 26]. External colonization by direct inoculation of or-
ganisms of the periurethral area at the time of catheter inser-
tion, or later, by ascending in the mucus film between the
catheter and the urethra, is the most frequent mechanism of
infection [26]. Once organisms gain access to the catheterized
urinary tract, the level of bacteriuria usually increases steadily
within 24 h–48 h [27]. Rate of acquisition of high-level bac-
teriuria is ∼5% per day [28]. The key control measure for the
prevention of infection is limiting catheter use and duration
[3, 7, 10]; both use and duration were reduced by our inter-
vention consistent with its impact. Urinary bladder and voiding
problems are common after surgical procedures, and their man-
agement remains controversial. Standard practice has been to
use an indwelling catheter to prevent postoperative retention
and bladder distension [18, 29]. Despite reduced recourse to
urinary catheterization at time of surgery, no increase in either
the postanesthesia care unit or in the surgical ward was ob-
served subsequent to our intervention, suggesting that standard
practice could be reviewed to the benefit of patient safety.
Enteric gram-negative organisms and enterococci recovered
from the catheterized urinary tract are commonly associated
with antimicrobial resistance [1, 3, 4, 7]. An important con-
sequence of our intervention is the decrease of antibiotic pre-
scription, which was clearly associated with a reduced incidence
of UTI. Whether the wider application of our strategy would
significantly impact on antimicrobial resistance acquisition in
hospitals deserves further testing.
Clinical guidelines are one option for improving quality of
patient care [1, 30]. It appears important to more-accurately
target patients in whom the insertion of a urinary catheter is
futile. In this study, several reasons accounted for guideline
acceptance. First, the guidelines were developed by a multidis-
ciplinary group of local experts and, although there was no
“physician champion” involved [31], the strategy was strongly
supported by the physician and nurse leaders in all departments
concerned [14, 32–34]. Second, they were tailored to local prac-
tice patterns and were based on available scientific evidence
[32–35]. Third, they were adapted to each location of patient
stay during the perioperative course, assuming the involvement
of all health care workers [34]. Importantly, our guidelines were
followed in 180% of cases, which compares favorably with
quality-improvement reports [34, 35]. Whether the additional
use of automatic computer-based protocols could further im-
prove compliance deserves further evaluation [36].
One of the most important results of our intervention is its
sustained impact. In particular, the frequency of catheter use
decreased in the operating room not only immediately after
guideline implementation, but also could be observed 2 years
later. Notably, this reduction (53% in 2 years) is paralleled by
a 64% decrease in the incidence of UTI and a significant re-
duction in antimicrobial use. Infection prevention is a critical
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component of patient safety [1] and has been recently selected
as the first challenge of the World Health Organization World
Alliance for Patient Safety [37]. Avoiding or shortening the
duration of use of a medical device is among the most powerful
strategies for the prevention of infection [1] and is proposed
in most guidelines, as well as in “bundle strategies,” such as
those proposed by the US Institute for Healthcare Improvement
[38]. However, availability of guidelines does not ensure their
application in everyday practice. Behavioral change remains a
formidable challenge [1, 39]. As reported previously and ap-
plied in the present study, effective interventions to promote
behavioral change must be multifaceted [14, 33–35, 38–42].
Feedback of performance and results was only made available
after the intervention but might have been critical to ensure
its sustained effect [34, 35, 40].
Our intervention differs in many respects from the approach
proposed by the US Institute for Healthcare Improvement “care
bundles” [38]. In particular, our study involves a concurrent
control group and a 2-year follow-up evaluation that was un-
obtrusive; performance feedback was not used during the in-
tervention. Furthermore, as proposed and used, guidelines for
urinary catheter use are new, are tailored to local practice pat-
terns and the population served, and have not been subject to
prior evaluation. Before use in “care bundles” on a larger scale,
our results merit further evaluation in other institutions.
This study has some limitations. First, it was performed at
a single medical center and deserves further testing in other
institutions. Second, although patients were prospectively fol-
lowed until hospital discharge, long-term postdischarge sur-
veillance was not conducted systematically for all patients; this,
however, does not affect the major study outcome. Third, un-
controlled factors, such as variations in physicians’ skills or
individual commitment to prevention, may have contributed
to the decreased infection rates. However, such confounders
are unlikely to explain both the overall impact and the long-
lasting effect of the intervention. Our study was classified as
B1 in the hierarchy of quasi-experimental study designs in the
fields of infection control and antimicrobial resistance [11].
UTI is common, economically costly, and morbid. Simple
guidelines designed for specific patient groups during the per-
ioperative period can decrease its incidence by 150% and re-
duce antibiotic use without increasing morbidity. By focusing
our strategy on anesthetists, the postanesthesia care unit, and
the surgical ward nursing staff, we emphasized their role in
preventing postoperative infection. Specific strategies to im-
plement guidelines are necessary to ensure significant changes
in practice and improve patient safety.
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